FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingrid Galán

Research Profile

Chemicals & Drugs

Disorders

Procedures

Disability Evaluation

Concepts & Ideas

Geographic Areas

Spain

Living Beings

JC Virus

Co-author Network

Publications

TOP 3
Carmen Tur; M José Vicente; Angela Vidal-Jordana; Carlos Nos; Jordi Río; Jaume Sastre-Garriga; Mar Tintoré; M Jesús Arévalo; Georgina Arrambide; Ana Caminero; Joaquín Castilló; Manuel Comabella; Ingrid Galán; Rosalía Horno; Xavier Montalban
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
Carmen Tur; Jaume Sastre-Garriga; Nieves Téllez; Mar Tintoré; Francesc Xavier Aymerich; Luis Brieva; David Calle; Manuel Comabella; Ingrid Galán; Xavier Montalban; Carlos Nos; Héctor Perkal; Jordi Río; Alex Rovira
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Raul Pelayo; Xavier Montalban
Interferon beta in secondary progressive multiple sclerosis : daily clinical practice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingrid Galán (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Carmen Tur; M José Vicente; Angela Vidal-Jordana; Carlos Nos; Jordi Río; Jaume Sastre-Garriga; Mar Tintoré; M Jesús Arévalo; Georgina Arrambide; Ana Caminero; Joaquín Castilló; Manuel Comabella; Ingrid Galán; Rosalía Horno; Xavier Montalban
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(8):1193-6.
2011: Carmen Tur; Jaume Sastre-Garriga; Nieves Téllez; Mar Tintoré; Francesc Xavier Aymerich; Luis Brieva; David Calle; Manuel Comabella; Ingrid Galán; Xavier Montalban; Carlos Nos; Héctor Perkal; Jordi Río; Alex Rovira
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Archives of neurology 2011;68(11):1421-7.
2007: Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Raul Pelayo; Xavier Montalban
Interferon beta in secondary progressive multiple sclerosis : daily clinical practice.
Journal of neurology 2007;254(7):849-53.
2006: Nieves Téllez; Jordi Río; Mar Tintoré; Carlos Nos; Ingrid Galán; Xavier Montalban
Fatigue in multiple sclerosis persists over time: a longitudinal study.
Journal of neurology 2006;253(11):1466-70.
2006: Jordi Río; Carlos Nos; Mar Tintoré; Nieves Téllez; Ingrid Galán; Raul Pelayo; Manuel Comabella; Xavier Montalban
Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients.
Annals of neurology 2006;59(2):344-52.
2005: Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Xavier Montalban
Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.
Journal of neurology 2005;252(7):795-800.
2005: Nieves Téllez; Jordi Río; Mar Tintoré; Carlos Nos; Ingrid Galán; Xavier Montalban
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(2):198-202.
2005: Jordi Río; Mar Tintoré; Nieves Téllez; Carlos Nos; Ingrid Galán; Xavier Montalbán
[Long-term effect of neutralizing antibodies to interferon beta-1 b in patients with multiple sclerosis].
Medicina clínica 2005;124(4):140-1.
2002: Jordi Río; Carlos Nos; Mar Tintoré; Cecilia Borrás; Ingrid Galán; Manuel Comabella; Xavier Montalban
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.
Annals of neurology 2002;52(4):400-6.
2002: Jaume Sastre-Garriga; Jordi Río; Carlos Nos; Ingrid Galán; Mar Tintoré; Xavier Montalbán
[Descriptive study of first visits in a multiple sclerosis specialised unit].
Neurología (Barcelona, Spain) 2002;17(4):179-82.